Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.7.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Apr. 30, 2017
Apr. 30, 2016
Current assets:    
Cash $ 155 $ 56
Accounts receivable, less allowance of $50 and $100, respectively 1,816 2,746
Inventories, net 945 1,336
Other current assets 442 123
Total current assets 3,358 4,261
Property and equipment, net 16 51
Other assets 34 30
Capitalized software development costs, net 274 326
Goodwill 1,083 1,083
Total assets 4,765 5,751
Current liabilities:    
Note payable-revolving credit line 1,340 1,776
Accounts payable 1,002 737
Accrued liabilities 102 159
Convertible notes payable - USG 250
Convertible notes payable related parties 80 80
Total current liabilities 2,774 2,752
Other liabilities 35 107
Total liabilities 2,809 2,859
Commitments and contingencies
Stockholders' equity:    
Common stock, par value $.001 per share Authorized 54,000,000 common shares; par value $0.001, issued and outstanding 1,204,667 at April 30, 2017 and 412,074 at April 30, 2016 1
Additional paid-in capital 29,581 24,558
Accumulated deficit (27,626) (25,711)
Total stockholders' equity 1,956 2,892
Total liabilities and stockholders’ equity 4,765 5,751
Series A Preferred Stock [Member]    
Stockholders' equity:    
Preferred stock value
Series B Preferred Stock [Member]    
Stockholders' equity:    
Preferred stock value 4,045
Series D Preferred Stock [Member]    
Stockholders' equity:    
Preferred stock value